You are here

Article metrics

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: August 2022 to August 2025

AbstractFullPdf
Aug 202214811504330
Sep 2022808823223
Oct 2022369375151
Nov 202235935967
Dec 202213714159
Jan 202322022555
Feb 202319720170
Mar 202318018062
Apr 202312813053
May 202311211472
Jun 2023919237
Jul 2023979732
Aug 2023767732
Sep 2023787837
Oct 2023878839
Nov 2023737323
Dec 2023838541
Jan 2024606033
Feb 2024686830
Mar 202410510775
Apr 2024969744
May 2024999848
Jun 2024676724
Jul 2024656729
Aug 2024605825
Sep 2024555634
Oct 2024585854
Nov 2024666946
Dec 202415215445
Jan 2025717466
Feb 202521621641
Mar 2025616141
Apr 202510010446
May 2025929246
Jun 2025606151
Jul 2025110
Aug 2025110
Total612962112161